Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jennifer Fostel
Affiliation
National Institute of Environmental Health Sciences
ORCID
Career Start Year
1980
Papers
67
H Index
33
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36909352
ToxicR: A computational platform in R for computational toxicology and dose-response analyses.
Comput Toxicol
2023
36909352
ToxicR: A computational platform in R for computational toxicology and dose-response analyses.
Comput Toxicol
2023
34751388
CEBS update: curated toxicology database with enhanced tools for data integration.
Nucleic Acids Res
2022
34751388
CEBS update: curated toxicology database with enhanced tools for data integration.
Nucleic Acids Res
2022
27899660
CEBS: a comprehensive annotated database of toxicological data.
Nucleic Acids Res
2017
28766826
The TGx-28.65 biomarker online application for analysis of transcriptomics data to identify DNA damage-inducing chemicals in human cell cultures.
Environ Mol Mutagen
2017
27899660
CEBS: a comprehensive annotated database of toxicological data.
Nucleic Acids Res
2017
28766826
The TGx-28.65 biomarker online application for analysis of transcriptomics data to identify DNA damage-inducing chemicals in human cell cultures.
Environ Mol Mutagen
2017
27128319
The Ontology for Biomedical Investigations.
PLoS One
2016
27128319
The Ontology for Biomedical Investigations.
PLoS One
2016
26232693
NIEHS/FDA CLARITY-BPA research program update.
Reprod Toxicol
2015
26232693
NIEHS/FDA CLARITY-BPA research program update.
Reprod Toxicol
2015
26361796
Mining the Archives: A Cross-Platform Analysis of Gene Expression Profiles in Archival Formalin-Fixed Paraffin-Embedded Tissues.
Toxicol Sci
2015
26361796
Mining the Archives: A Cross-Platform Analysis of Gene Expression Profiles in Archival Formalin-Fixed Paraffin-Embedded Tissues.
Toxicol Sci
2015
24836576
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.
Nat Med
2014
25012808
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.
Sci Rep
2014
24836576
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.
Nat Med
2014
25012808
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.
Sci Rep
2014
23303777
Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.
Nucleic Acids Res
2013
23303777
Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.
Nucleic Acids Res
2013
23664763
Transcriptional and epigenetic dynamics during specification of human embryonic stem cells.
Cell
2013
23664763
Transcriptional and epigenetic dynamics during specification of human embryonic stem cells.
Cell
2013
22400915
Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.
Antioxid Redox Signal
2012
22400915
Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.
Antioxid Redox Signal
2012
23034176
Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling.
Genome Biol
2012
22230429
Sources of variance in baseline gene expression in the rodent liver.
Mutat Res
2012
23034176
Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling.
Genome Biol
2012
22230429
Sources of variance in baseline gene expression in the rodent liver.
Mutat Res
2012
22039513
Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice.
PLoS One
2011
22369133
Maximizing biomarker discovery by minimizing gene signatures.
BMC Genomics
2011
22039513
Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice.
PLoS One
2011
22369133
Maximizing biomarker discovery by minimizing gene signatures.
BMC Genomics
2011
20100679
Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science Subcommittee.
Environ Health Perspect
2010
21304730
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop.
Stand Genomic Sci
2010
20935265
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
J Natl Cancer Inst
2010
20826374
Protective role of interleukin-10 in ozone-induced pulmonary inflammation.
Environ Health Perspect
2010
20676074
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Nat Biotechnol
2010
20100679
Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science Subcommittee.
Environ Health Perspect
2010
20626927
Modeling biomedical experimental processes with OBI.
J Biomed Semantics
2010
21304730
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop.
Stand Genomic Sci
2010
20826374
Protective role of interleukin-10 in ozone-induced pulmonary inflammation.
Environ Health Perspect
2010
20935265
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
J Natl Cancer Inst
2010
20626927
Modeling biomedical experimental processes with OBI.
J Biomed Semantics
2010
20676074
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Nat Biotechnol
2010
19465456
Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.
Toxicol Sci
2009
19465456
Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.
Toxicol Sci
2009
19374479
Creating a controlled vocabulary for the ethics of human research: towards a biomedical ethics ontology.
J Empir Res Hum Res Ethics
2009
19925653
Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis.
Mol Cancer
2009
19925653
Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis.
Mol Cancer
2009
19374479
Creating a controlled vocabulary for the ethics of human research: towards a biomedical ethics ontology.
J Empir Res Hum Res Ethics
2009
1 - 50 of 134
Column Actions
Search
Recommended Authors
Robert M Flight
University of Kentucky
Career Start Year
2007
Number of shared co-authors
1
Linh-Chi Bui
INSERM UMR-S1124, Universite Paris Cite
Career Start Year
2005
Number of shared co-authors
0
Reuben Thomas
Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes
Career Start Year
2004
Number of shared co-authors
5
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
2003
Number of shared co-authors
3
Scott H Harrison
North Carolina Agricultural and Technical State University
Career Start Year
2002
Number of shared co-authors
3
Heather Butler
SGS-AXYS Analytical Services Ltd.
Career Start Year
2000
Number of shared co-authors
3
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
2
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year
1999
Number of shared co-authors
13
Ralf Herwig
Max Planck Institute for Molecular Genetics
Career Start Year
1998
Number of shared co-authors
1
Kristen Jensen-Pergakes
Pfizer Inc. San Diego
Career Start Year
1998
Number of shared co-authors
0
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year
1997
Number of shared co-authors
20
Yingyao Zhou
Genomics Institute of the Novartis Research Foundation
Career Start Year
1997
Number of shared co-authors
1
John Calley
Lilly Research Laboratories
Career Start Year
1995
Number of shared co-authors
0
Christopher T Workman
Technical University of Denmark
Career Start Year
1995
Number of shared co-authors
2
Katrina M Waters
Pacific Northwest National Laboratory
Career Start Year
1994
Number of shared co-authors
3
Gary Hardiman
Institute for Global Food Security, Queen's University Belfast
Career Start Year
1994
Number of shared co-authors
1
Ioannis Xenarios
University of Lausanne
Career Start Year
1994
Number of shared co-authors
25
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
2
Hans Gmuender
F. Hoffmann-La Roche Ltd
Career Start Year
1993
Number of shared co-authors
2
Jiri Adamec
University of Nebraska (UNL)
Career Start Year
1993
Number of shared co-authors
0
Philip J R Day
University of Cape Town
Career Start Year
1988
Number of shared co-authors
2
Francois Pognan
Novartis
Career Start Year
1988
Number of shared co-authors
0
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year
1987
Number of shared co-authors
1
Manuel C Peitsch
Philip Morris International Research Laboratories Pte. Ltd
Career Start Year
1987
Number of shared co-authors
2
Stuart L Schreiber
Broad Institute
Career Start Year
1985
Number of shared co-authors
6
Chris T Evelo
Maastricht University
Career Start Year
1984
Number of shared co-authors
24
Jos C S Kleinjans
Maastricht University
Career Start Year
1981
Number of shared co-authors
20
Stephen H Friend
University of Oxford
Career Start Year
1978
Number of shared co-authors
4
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year
1975
Number of shared co-authors
8
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year
1968
Number of shared co-authors
17
row(s) 1 - 30 of 30
Collaborators
Philippe Rocca-Serra
University of Oxford
Co-authored papers
11
Susanna-Assunta Sansone
Oxford e-Research Centre, University of Oxford
Co-authored papers
11
Pierre R Bushel
Co-authored papers
9
Norman Morrison
European Bioinformatics Institute
Co-authored papers
9
Weida Tong
National Center for Toxicological Research
Co-authored papers
8
Chris F Taylor
European Molecular Biology Laboratory- European Bioinformatics Institute
Co-authored papers
7
Christian J Stoeckert
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
6
Helen Parkinson
European Bioinformatics Institute
Co-authored papers
6
Ryan R Brinkman
University of British Columbia
Co-authored papers
5
Patricia L Whetzel
University of Colorado Anschutz Medical Campus
Co-authored papers
5
Liju Fan
Hebei General Hospital Shijiazhuang 050051 Hebei China.
Co-authored papers
5
Michael D Waters
Washington University School of Medicine
Co-authored papers
5
Dawn Field
Biodiversity Institute, University of Oxford
Co-authored papers
4
Mervi Heiskanen
National Cancer Institute
Co-authored papers
4
Richard S Paules
Co-authored papers
4
Barry Smith
University at Buffalo
Co-authored papers
4
Gilberto Fragoso
NCI Center for Bioinformatics, National Cancer Institute
Co-authored papers
4
Daniel Schober
Institute of Forensic Medicine, University of Bern
Co-authored papers
3
Phillip Lord
Newcastle University
Co-authored papers
3
Alvis Brazma
European Bioinformatics Institute
Co-authored papers
3
Nigel Hardy
Co-authored papers
3
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers
3
Nianqing Xiao
Co-authored papers
3
John Quackenbush
Harvard T. H. Chan School of Public Health
Co-authored papers
3
David J Dix
Co-authored papers
3
Tieliu Shi
Co-authored papers
2
Dirk Derom
The Vrije Universiteit Brussel
Co-authored papers
2
Richard H Scheuermann
J. Craig Venter Institute
Co-authored papers
2
Stefan Wiemann
Co-authored papers
2
Tina Hernandez-Boussard
Stanford University
Co-authored papers
2
1 - 30